Repligen Corp (NAS:RGEN)
$ 166.895 -4.885 (-2.84%) Market Cap: 9.33 Bil Enterprise Value: 9.56 Bil PE Ratio: 667.58 PB Ratio: 4.73 GF Score: 93/100

Repligen Corp at Stifel Virtual Healthcare Conference Transcript

Nov 18, 2020 / 03:40PM GMT
Release Date Price: $185.45 (-4.16%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome, everybody, to Day 3 of the 2020 Stifel Healthcare conference. This is the Life Sciences and Diagnostic track. And we're happy to have Repligen as the next company with us today.

Today, right now, I have Jon Snodgres, who's the CFO; and then Tony Hunt, the CEO, will be joining us in a little bit, once we wrap some things up. So Jon, welcome. Thanks for spending some time.

Jon K. Snodgres
Repligen Corporation - CFO & Secretary

It's our pleasure to be here. Thank you, Dan.

Questions & Answers

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Yes, for sure. I think maybe just a good starting point would be to talk about the year. I mean 2020 has been an active year for everybody. But certainly for you guys, just given the customers that you serve and what those customers have been doing this year, can you just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot